Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Carillon Eagle Growth & Income Fund's investment thesis on iRhythm Technologies ($IRTC) — Q1 2026 | Buyside Digest

$IRTCNASDAQiRhythm Technologies

BULL

Carillon Eagle Growth & Income Fund—IRTC

Fund Letter

Q1 2026

Published April 18, 2026

$120.25USD

-2.3% vs last month

$122.35Pitched

-1.7% since pitch

Market Cap$4.1B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

iRhythm Technologies is a digital healthcare company that develops wearable, AI-driven cardiac monitoring devices. The stock struggled...

— Brad Erwin, Jeffrey D. Bilsky, Michael Rich

BSD Research Exclusive

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

Other investors who've written on iRhythm Technologies

No other institutional pitches found for this ticker yet.